ESR1 and breast carcinoma: Tamoxifen also activates apoptosis of breast cancer cells in an ERα-independent manner by regulating several signaling targets including protein kinase C, transforming growth factor β, calmodulin, mitogen-activated protein kinase p38 and c-Jun terminal kinase7.